Abstract: Among individuals with substance use disorders (SUDs), comorbidity with other psychiatric disorders is common and often noted as the rule rather than the exception. Standard care that provides integrated treatment for comorbid diagnoses simultaneously has been shown to be effective. Technology-based interventions (TBIs) have the potential to provide a cost-effective platform for, and greater accessibility to, integrated treatments. For the purposes of this review, we defined TBIs as interventions in which the primary targeted aim was delivered by automated computer, Internet, or mobile system with minimal to no live therapist involvement. A search of the literature identified nine distinct TBIs for SUDs and comorbid disorders. An examination of this limited research showed promise, particularly for TBIs that address problematic alcohol use, depression, or anxiety. Additional randomized, controlled trials of TBIs for comorbid SUDs and for anxiety and depression are needed, as is future research developing TBIs that address SUDs and comorbid eating disorders and psychotic disorders. Ways of leveraging the full capabilities of what technology can offer should also be further explored.
INTRODUCTION
Of the 20 million individuals with substance use disorders (SUDs), approximately 40% also have a comorbid mental illness. 1 Individuals with comorbid diagnoses seek treatment significantly more often than those with a single diagnosis, 2 with greater economic costs associated with their care. 3 Although empirically based integrated treatments that address comorbid disorders simultaneously are recommended, they are limited in availability and accessibility to patients. 4 Barriers to accessing treatment have also been noted for individuals with comorbid substance use and mental health disorders, including psychosocial instability, low motivation, deficits in socialinteraction skills, and concerns about stigma. 5 Thus, it is not surprising that less than 55% of individuals with SUDs and comorbid diagnoses report receiving professional treatment. [6] [7] [8] Technology-based interventions (TBIs) have the potential to address some of the treatment challenges of comorbidity by providing an easily accessible, cost-effective alternative to in-person services. A variety of terms has been used in the literature to refer to TBIs, including computer-assisted therapies, 9 computer-based interventions, 10 web-based interventions, 11 and internet-based interventions. 12 Other common terms include mHealth (mobile health) and eHealth (electronic health). mHealth simply refers to health services accessed using either mobile handheld devices such as smartphones or tablets (e.g., texting, apps) or wearable sensors such as smart watches and various sensing devices, whereas eHealth is a broader, umbrella term for using any electronic communication, often via the Internet (e.g., electronic health records, telemedicine). We prefer to use the term technology-based interventions because it encompasses a broad array of platforms, including the computer, Internet, and mobile applications.
TBIs can be easily disseminated and used in a number of locations, including residential, outpatient, and community treatment settings, as well as in home or public settings with an Internet connection. 13, 14 Mobile applications offer additional flexibility in that users can access these applications at almost any time using handheld mobile devices, which can be an invaluable service for patients during difficult or triggering social situations. 15 For those with financial limitations who are unable to afford inpatient or outpatient treatment services, TBIs could offer a cost-effective alternative. 14, 16 These interventions are also a helpful solution for patients who lack childcare or reliable transportation, have scheduling conflicts with outpatient services, 14 or are not ready to seek formal services due to motivation or stigma. Consequently, such interventions have not only the ability to reach a larger number of individuals but also a wider demographic. 13 TBIs for Substance Use Disorders Several reviews and meta-analyses provide support for the acceptability, feasibility, and efficacy of TBIs for SUDs. [10] [11] [12] [17] [18] [19] [20] [21] [22] [23] [24] These interventions for SUDs have been used for assessment, 25, 26 prevention (most often in the form of screening and brief intervention), [27] [28] [29] [30] [31] treatment, 32, 33 and recovery and aftercare. 34, 35 In regard to specific types of substances, a substantial literature for TBIs has focused on decreasing alcohol use. Meta-analyses and reviews of the literature have found that TBIs for problematic alcohol use decrease alcohol consumption (i.e., quantity and frequency) and negative consequences of use. 20, 22, [36] [37] [38] Similar results have been found with nicotine users, such that smoking-cessation TBIs have been found to be effective overall in decreasing smoking frequency and in initiating and sustaining abstinence. [39] [40] [41] Although the literature is limited, mobile and computer interventions for other substances show promise, particularly for reducing marijuana, 24 stimulant (e.g., methamphetamine 42 and cocaine 43 ), and opioid use.
32,44
TBIs for Other Psychiatric Disorders Empirical evidence supports the use of TBIs for preventing and treating other psychiatric disorders, including depression and anxiety, [45] [46] [47] [48] [49] psychotic disorders, 50 and eating disorders. 51 The largest body of literature on TBIs for psychiatric disorders focuses on interventions for depression and anxiety (for review see Andrews G et al., 52 Davies EB et al., 53 and Ebert DD et al. 54 ). Mobile technologies have also been used to assess suicidal ideation among depressed individuals. 55 TBIs have been reported to improve schizophrenia symptoms 50, 56 and also eating disorder symptoms when used as an addition to other treatment services. 57 
Comorbid Disorders
Although the existing literature on TBIs is positive overall with respect to acceptability and efficacy, most TBIs target a single disorder. It is uncommon, however, for an individual to present to treatment with a single diagnosis. Rather, many patients have comorbid disorders-which is especially true of individuals with SUDs. 58 Integrated treatments delivered in person in individual and group formats that address symptoms of SUDs and comorbid disorders simultaneously have been shown to be effective, [59] [60] [61] and often more effective than treatment of individual disorders separately or in sequence. 62 Therefore, the importance of developing TBIs for comorbid SUDs and other mental disorders is high. Only a handful of TBIs is currently available, however, for co-occurring SUDs and other disorders. The purpose of this review is to establish the current state of science for TBIs that target SUDs and comorbid disorders and to provide guidance on plausible and needed next steps to increase the accessibility and effectiveness of these interventions.
METHODS
Between March 2016 and June 2016, we used PubMed and PsycINFO to search for existing TBIs for co-occurring SUDs and other disorders. The following search terms were used in various combinations: (technology or technology based intervention or computer or computer intervention or mobile or mobile application or mobile intervention or text message or Smartphone or internet or internet-based intervention) AND (substance use or substance use disorder or substance abuse or alcohol or alcohol use disorder or opioid or heroin or marijuana or stimulant or cocaine or methamphetamine) AND (comorbid or co-occur* or depression or anxiety or post-traumatic stress disorder or PTSD or eating disorder or borderline personality disorder). We also identified manuscripts by searching through article references. For the purposes of this review, we defined TBIs as interventions in which the primary targeted aim of the intervention was delivered by automated computer, Internet, or mobile system with minimal to no live therapist involvement. This definition was based on other reviews in the literature of TBIs for SUDs. 9, 10, 14 We excluded articles on e-therapy and telehealth, including, therapist-delivered text messaging, email exchanges, and video or audio conferencing. Text-messaging interventions were included if the texts were automated, as these TBIs do not simulate live contact with a therapist (i.e., e-therapy). Applications and systems in which the primary aim was assessment were not considered interventions and were thus excluded, as were non-English articles. Articles were included if the TBI was designed to address both substance use and another co-occurring disorder. In an effort to examine the literature in this nascent field, we included feasibility and acceptability pilot studies, published protocols of studies that had not yet begun, and, of course, randomized, control trials (RCTs).
We identified 14 articles that examined nine distinct TBIs that met our search criteria. The comorbidity combinations varied across studies, with four TBIs developed for SUDs and depression, [63] [64] [65] [66] [67] [68] [69] two for SUDs and posttraumatic stress disorder (PTSD), [70] [71] [72] [73] one for SUDs and borderline personality disorder, 74 and two for SUDs, depression, and anxiety. 75, 76 Table 1 provides a description of the studies that have examined these TBIs. Technology-Based Interventions for Substance Use and Comorbid Disorders targeted comorbid SUDs and PTSD. 71 Comparison groups varied widely among the RCTs and included active treatment with a live therapist, 63, 64 active online intervention, 69 online attention-control, 66 delayed intervention, 71 and generic "thank you" text messages (of non-compared attention to TBI). 67 A computer-based intervention developed for depression and comorbid alcohol or other drug use entitled Self-Help for Alcohol and Other Drug Use and Depression (SHADE) was initially tested in an RCT with a small sample 63 and then replicated in a larger RCT. 64 SHADE is a nine-session, manualized treatment that incorporates techniques from both cognitivebehavioral therapy (CBT) and motivational interviewing, and was originally developed as a therapist-delivered treatment. In the initial RCT, participants received a brief, in-person intervention (BI). They were subsequently randomized to receive therapist-delivered SHADE, computer-delivered SHADE, or no additional treatment (BI only). The content delivered in both SHADE groups was the same. Results of the initial RCT showed significant reductions in alcohol and cannabis use across all intervention groups. In regard to overall reduction in alcohol use (baseline to 12 months), no significant differences were found between the intervention groups. For overall reductions in cannabis use, both SHADE groups were equivalent in reductions but produced significantly greater reductions compared to BI only (effect size difference of 0.76 for in-person vs. BI only; effect size difference of 1.11 for computer vs. BI only). Depressive symptoms also decreased significantly across all intervention groups, with the in-person SHADE showing the quickest reduction, which was then matched by the computerized SHADE at the 12-month follow-up. Both SHADE groups (computer and in-person) outperformed the BI-only group in depressive symptoms reduction (effect size difference of 0.31 for in-person vs. BI-only; effect size difference of 0.27 for computer vs. BI only). Furthermore, engagement (i.e., sessions completed) in the in-person and computerized SHADE groups did not differ.
A larger, replication RCT compared computerized SHADE, therapist-delivered SHADE, and supportive counseling (therapist delivered). 64 Participants in both SHADE groups had greater reductions in alcohol use at three-month follow-up compared to supportive counseling, and participants receiving computerized SHADE had 2.5 times greater reductions compared to therapist-delivered SHADE. No significant differences between groups were found in regard to reductions in cannabis use. Both SHADE groups were associated with greater reductions in depressive symptoms compared to supportive counseling; however, no significant differences between the two SHADE groups (computer vs. therapist) were found. Interestingly, in subsequent analyses, although the majority of participants indicated a preference for therapist-delivered treatment prior to randomization, posttreatment scores of satisfaction with treatment were equivalent for computer versus therapistdelivered SHADE. 65 SHADE has recently been adapted for young adults with depressive symptoms and problematic alcohol use. 66 The resulting TBI (named DEAL: DEpression-ALcohol) is a fourmodule, one-hour weekly, Internet-based intervention that includes CBT and motivational-interviewing techniques with homework exercises. Participants in this study were randomized to receive DEAL or four modules of online generic health information and assessments (HealthWatch). Significant differences were observed between the groups, with the DEAL group showing greater reductions in alcohol use and improvement in depressive symptom severity compared to the HealthWatch group at posttreatment (five weeks) but not at three-or six-month follow-up time points. Posttreatment effect sizes were large (reduction in depression severity = 0.71; reduction in drinks per week = 0.99 and in drinking days per week = 0.76), whereas six-month follow-up effect sizes were small to moderate (0.09-0.39). Treatment retention was low for this sample, and participants in the DEAL group completed significantly fewer sessions than those in the HealthWatch group (1.5 vs. 2.5 sessions, respectively).
Another TBI addressing problematic alcohol use and depressed mood was designed and tested as a preventive intervention for college students. 69 Unlike the TBIs described above, which included multiple sessions/modules, this TBI was a single-session intervention of brief personalized feedback modeled from social-norm approaches that have been shown to be efficacious in reducing heavy alcohol use and related consequences in college students. 77 The integrated intervention was compared to two TBIs targeting single symptoms (alcohol only and mood only) and to an assessment-only control condition. Materials from the alcohol-and mood-only interventions were combined to create the integrated intervention, and additional information on the relationship between depression and alcohol was also included. Unfortunately, no significant differences were observed among conditions with respect to alcohol use and depressive symptoms.
A supportive text-messaging TBI focusing on comorbid depression and SUDs has been tested as an addition to standard care for individuals with major depressive disorder and alcohol use disorder. 67 This intervention sends participants two automated, supportive text messages daily for three months with content on stress management, abstinence, and overall well-being. A pilot RCT compared participants who received the intervention to those in a control group who received generic, once-fortnightly "thank you" messages for three months. Reduction in depressive symptoms was significantly greater for those in the intervention group than in the control group (effect size = 0.85), although alcohol abstinence rates were not significantly different between groups (effect size = 0.51). Considering the low interactivity and non-personalized messages of the intervention, it is promising that the messages were still capable of producing significant reductions in depressive symptoms.
The last TBI to be examined in an RCT was VetChange, which is a Web-based intervention for Operation Enduring Freedom and Operation Iraqi Freedom veterans with problem alcohol use and PTSD symptoms. 70, 71 VetChange consists of eight 20-minute weekly psychoeducational and interactive Web-based modules that provide personalized feedback on severity of alcohol problems and PTSD symptoms, assess readiness to change, and help users to identify high-risk situations, set goals, and develop adaptive coping skills. The modules also encourage veterans to build a strong social support network. Users receive weekly, personalized progress reports at the end of each module. Participants were randomized to the intervention group or a delayed-treatment (eight weeks) control group. Those who received the intervention first showed significantly greater decreases in alcohol use and PTSD symptoms than participants in the delayed-treatment group. Participants in the delayed-treatment group demonstrated a similar pattern of reductions as the initial treatment group after receiving the intervention. One limitation of the study, however, was its low level of sustained engagement. Despite the high rates of completion of the first module (90% intervention group; 88% delayed group), just over half of the sample (54% intervention and 58% delayed) completed four modules, and only 34% of the intervention group and 39% of the delayed-treatment group completed all eight modules. The authors conducted a secondary analysis of data from the VetChange RCT to examine the relationship between drinking outcomes and participants' drinking goals. 72 Results showed that participants more often chose a goal of moderation compared to abstinence; alcohol reductions were observed three months post-intervention regardless of goal choice.
Uncontrolled Pilot, Feasibility, and Acceptability Studies Two small pilot studies examined feasibility, acceptability, and preliminary efficacy of novel TBIs for comorbid SUDs and other mental illnesses. DBT Coach is an interactive mobile phone application created for individuals with co-occurring SUDs and borderline personality disorder. 74 In a pilot study, the DBT Coach app was developed and assessed for feasibility as an addition to standard dialectical behavior therapy. DBT Coach provides coaching in the DBT skill of opposite action, which is an emotion-regulation skill hypothesized to decrease emotional intensity and urges to use substances. Participants were instructed to use DBT Coach as often as needed for 10-14 days. Daily surveys were conducted via the app, asking about emotions, urges to use substances, and the overall helpfulness of DBT Coach. Participants were directed to different questions and tips, depending on their answers to the prior screen, thus allowing for a more personalized experience. On average, participants used the app 15 times over the 10-14 days and were highly compliant with daily assessments (85% completed). Participants rated DBT Coach highly in regard to its usability and helpfulness, and preliminary analyses show that both intensity of emotions and substance-use urges reduced significantly after each session. In addition, self-reported confidence in applying the skill of opposite action increased throughout the trial. The authors reported that they are working on expanding DBT Coach to include more DBT skills.
The second pilot study assessed feasibility of a Web-based computer program for individuals affected by disaster who are struggling with substance use and with depression and anxiety. 75 This TBI consisted of seven modules that provide psychoeducation and coping strategies for dealing with substance use and other mental health issues, including (1) marijuana, (2) alcohol, (3) nicotine, (4) other drugs, (5) depression, (6) worry/anxiety, and (7) posttraumatic stress/panic. Participants qualified for each interactive module based on their screening responses, and the modules themselves were personalized based on screening questions about symptoms. Participants were recruited from a larger epidemiological study of New York City residents initially recruited six months after the September 11, 2001 , terrorist attacks. The use of a documented probability sample allowed the researchers to compare participants to nonparticipants on a number of characteristics. Overall, 31% of invited participants logged onto the study website, and 28% consented to the study. Compared to nonparticipants, participants were more likely to be male, of Asian descent, have greater education, and report better overall health. Completion rates for modules ranged from 64% (depression and smoking modules) to 36% (drug and worry/anxiety modules). Almost all (98%) participants stated that the intervention was easy to use, and 80% gave positive answers with regard to the intervention's helpfulness. Changes in symptoms or substance were not assessed in this feasibility study.
Published Research Protocols and Descriptions of Program Development
A small number of recently developed TBIs have yet to be tested in a pilot study or RCT. We identified two published study protocols of RCTs 68, 76 and one manuscript describing the development process of a TBI for PTSD symptoms and problematic substance use. 73 The Internet Treatment for Alcohol and Depression (iTreAD) study is currently examining various combinations of the Webbased intervention DEAL (described above) for co-occurring binge drinking and depression in young adults. 68 Three groups will be compared: (1) online monthly assessments only, (2) online monthly assessments plus DEAL, and (3) online monthly assessments plus DEAL plus access to a social-networking community, Breathing Space. In this closed social-networking community, moderated by research clinicians, participants are asked to share their thoughts, successes, and challenges related to drinking and their moods, and also to share messages of support with other participants. Outcome measures will include change in depressive symptoms and frequency of binge drinking assessed at 26, 39, 52, and 64 weeks post-baseline.
Similar to VetChange (also described above), Coming Home and Moving Forward is a Web-based intervention developed for veterans with SUDs and PTSD. 73 The intervention targets recent combat veterans from the wars in Afghanistan and Iraq. To inform the development of the intervention, the authors obtained feedback from clinicians and from focus groups with veterans who screened positive for hazardous substance use and PTSD symptoms. The intervention was then beta tested individually by 34 veterans. The final product includes twenty-four 15-to 25-minute interactive modules that utilize CBT and motivational-interviewing techniques, including skills-building exercises, challenging automatic thoughts, and readiness to change. Coming Home and Moving Forward also assesses substance use and PTSD symptoms, offers a workbook of exercises, and provides graphs of personal progress. Data from beta testing showed a significant increase in knowledge scores from pre-to post-test. An RCT is currently under way to test the intervention as an addition to treatment as usual (compared to a treatment as usual-only control group), with a target sample size of 164 veterans. Primary outcome measures will include substance use, PTSD symptoms, and quality of life assessed immediately posttreatment and at one and three months posttreatment.
Finally, an RCT using cluster randomization is under way to test the effectiveness of an Internet-based intervention called CLIMATE Schools Combined (CSC), aimed at preventing and reducing substance use, depressive symptoms, and anxiety among students aged 13 to 15 years in 84 Australian schools. 76 CSC is a combination of two previously developed interventions: CLIMATE Schools-Substance Use and CLIMATE Schools-Mental Health. Results from an RCT of the CLIMATE Schools-Substance Use intervention showed significant reductions in alcohol and cannabis use, and improvements in knowledge about substance use. 78, 79 The combined, CSC program includes an individual Internet-based component and a manualized classroom component, with 12 lessons focused on substance use and 6 lessons focused on mental health (i.e., depression and anxiety). Schools that agree to participate in the study are randomized to receive (1) CSC, (2) CLIMATE Schools-Substance Use only, (3) CLIMATE Schools-Mental Health only, or (4) usual health-education courses (control group). Outcomes will focus on reducing substance use, anxiety, and depressive symptoms and increasing knowledge related to substance use and mental health.
DISCUSSION
The emerging research on TBIs for comorbid SUDs and other psychiatric disorders shows promising results; however, this area is very limited and varied, and requires much growth. Five TBIs for comorbid SUD and other psychiatric disorders were tested in six RCTs. The methodological quality of the studies varied substantially, with only three studies including an active comparison group, 63, 64, 69 and three studies reporting effect sizes. 63, 66, 67 Review of the six RCTS revealed that the two TBIs with the strongest support are VetChange 71 and computer-delivered SHADE, 63, 64 as both of these skills-focused TBIs were associated with reduced psychiatric symptoms and substance use. The evidence for computer-delivered SHADE is particularly compelling in that it is the only TBI that has been compared to an in-person equivalent and tested in a replication study. 63, 64 Results showed that computer-delivered SHADE was equivalent to therapist-delivered SHADE in reducing depressive symptoms and substance use and that it even outperformed therapist-delivered SHADE in reducing alcohol use. 63, 64 These findings have important implications for delivering cost-effective, evidence-based treatment. In particular, computerdelivered SHADE required an average of 16 minutes of clinician time per session, compared to 60 minutes for therapist-delivered SHADE. 64 Thus, effective TBIs like SHADE could be beneficial in reducing the time burden on clinicians treating individuals with comorbid diagnoses.
Evidence is less robust for low-intensive and brief TBIs. A low-intensity, supportive text-messaging intervention was shown to reduce depressive symptoms but not alcohol use. 67 The two TBIs that were designed for young-adult populations were brief in duration (four sessions 66 and one session 69 ). Although short-term reductions in alcohol use and depression severity were observed for the four-session DEAL intervention, 66 these reductions were not sustained at longer followup points. In addition, a single-session integrated intervention was not found to be efficacious in reducing alcohol use and depressive symptoms even in the short-term (one month postintervention). 69 Thus, the duration and intensity of TBIs appear to be important factors in efficacy of TBIs for comorbid symptoms. The current RCT that is investigating DEAL in combination with social networking allows participants to access the intervention for 12 months. It will be important to learn if extending the duration and intensity of this intervention affects longer-term outcomes and whether participation can be sustained over time.
Feasibility and acceptability was demonstrated for TBIs focused on co-occurring SUDs and borderline personality disorder 74 and on disaster-affected individuals with substance use, depression, or anxiety; 75 however, the effect of these TBIs on substance use and psychiatric outcomes has yet to be tested in controlled trials. Data from the study with disaster-affected individuals 75 revealed differences in gender, race, education level, and overall health between participants and nonparticipants. Thus, efforts to engage a representative sample of participants in future research trials are needed, as well as data collection focused on reasons for participation in, and acceptability of, the intervention by demographic subgroups.
Three RCTs of new TBIs are currently under way 68, 73, 76 that will add to the literature in novel ways. The iTreAD study will examine a TBI with added access to a socialnetworking support community. Nearly 65% of adults in the United States use social-networking sites, and among young adults, the percentage increases to 90%. 80 Thus, the potential to provide supportive services through a platform that many people are already using could increase engagement rates and leverage the unique strengths of technology. Similarly, the Climate Schools Combined intervention aims to use an Internetbased TBI to engage school-age children in universal prevention for substance use and mental health problems. 76 Similar to VetChange, Coming Home and Moving Forward is directed at recent combat veterans. 73 TBIs that address comorbidity for this population are needed, given the high rates of both SUDs and PTSD observed in previous studies. 81, 82 Participants will be recruited from Veterans Administration primary care clinics in an effort to provide integrated treatment to veterans, who may be reluctant to seek help in specialty mental health clinics.
Our examination of the literature revealed that the majority of the TBIs addressed alcohol use, depression, or some form of anxiety. 63, 64, [66] [67] [68] 71, 73, 75, 76 This focus is not surprising, given that research on TBIs for single disorders has largely focused on alcohol, depression, and anxiety. Two potential areas for growth in regard to TBIs for SUDs and comorbid diagnoses are eating disorders and psychotic disorders. A high percentage of individuals with eating disorders report problems with substances, with prevalences of co-occurring SUDs and eating disorders estimated to be upward of 46% in clinical and community populations. 83 In addition, there is a high co-occurrence of SUDs and non-substance-induced psychotic symptoms. 84 Therefore, TBIs for these individuals could be particularly useful. A pilot study using live text messaging between a therapist and individuals with psychotic disorders found that participants reported the intervention to be helpful. 85 This intervention was not included in our review of comorbid TBIs, because the primary treatment (live text messaging with clinicians) was considered e-therapy. This study provides support, however, for the potential acceptability of a mobile app for individuals with comorbid SUDs and psychotic disorders.
The extent of integrated treatment for co-occurring SUD and other psychiatric disorders was variable among the TBIs reviewed. At the highest level of integration were TBIs that presented information on the association between substance use and the targeted psychiatric disorders and that also provided skills aimed to cut across the different diagnoses. Several TBIs met this level of integration (SHADE, VetChange, DEAL, and Coming Home and Moving Forward). 63, 64, 66, 68, 71, 73 DBT Coach focused on one integrated skill that was hypothesized to reduce urges to use substances and decrease emotional intensity common in individuals with borderline personality disorder. 74 The intervention for college students with depressive symptoms and problematic alcohol use provided integrated information, but strategies were separated by symptom. 69 Three TBIs were not considered integrated, such that separate modules or text messages were presented to address each targeted symptom or problem. 67, 75, 76 Patient engagement and adherence with TBIs is an important factor to consider when evaluating the literature. A previous review of computer-assisted therapies for psychiatric disorders found that few studies reported rates of engagement/ completion. 9 The initial SHADE trial 63 did not find any differences between computer versus in-person delivery in regard to the number of sessions completed. Other studies, however, reported much lower levels of engagement. Participants assigned to DEAL completed fewer sessions than those assigned to the control group, and only 68% of intervention participants completed at least one module. 66 The VetChange study 71 reported high rates of completion for the first module, but only a third of the sample completed all eight modules. Another study found that completion rates varied by topic, with more participants completing modules related to depression and smoking and fewer participants completing modules that targeted drugs and anxiety. 75 Future research should examine methods to improve engagement with TBIs (e.g., incentives, "gamification" of interventions, and adding some clinician involvement) and also investigate the optimal "dose" of TBIs for substance use and comorbid disorders.
Given the early state of this field of research, the literature is focused mainly on feasibility and outcomes, with sparse discussion of barriers to implementation of TBIs for substance use and co-occurring disorders. One issue of importance for substance use and psychiatric populations is safety monitoring of patients engaged in a TBI without live contact with therapists. Only one study explicitly discussed their process for dealing with reported suicidal ideation. 75 Another study is currently using research clinicians to monitor the social-networking aspect of the study for crisis management and inappropriate posts. 68 The feasibility of employing this level of monitoring outside of a research setting is unknown. One study has examined dissemination of SHADE in a substance use disorder clinical setting. 86 Results of this study showed that, although clients reported a high level of willingness to engage in the TBI, clinicians used the SHADE program with only 34% of their clients. Thus, it is vital that we understand barriers that clinicians and programs may face in implementing TBIs with their clients.
The majority of TBIs for comorbid SUDs and other diagnoses have focused on adapting traditional clinician-delivered content for delivery via computer, Internet, or mobile phone. Using technology in this way allows treatment to be delivered with guaranteed fidelity and also allows patients 24/7 access to the treatment. This is an important first step in developing TBIs that address comorbid illnesses. We should also consider, however, ways to further take advantage of what technology has to offer (e.g., biosensors, video, additional social interactions, gamification), which may require using the treatmentdevelopment model with technology interventions from the ground up rather than relying on previously developed, cliniciandelivered treatments that are translated to technology.
Some limitations of this review should be noted. As this area of research is an emerging one, only a limited number of studies were available to review. Furthermore, we relied on the information that was available in the published articles. Some details related to the study or the TBI may have been omitted due to space restrictions from journals. We also restricted our search to published literature and did not search NIH Reporter or ClinicalTrials.gov for National Institutes of Health trials that are currently in process. The reason for not including unpublished studies, as well as studies and protocols from NIH Reporter or ClinicalTrials.gov, was that the methods and procedures could be subject to change, or even outdated, before publication.
Overall, the emerging literature on TBIs that address SUDs and comorbid psychiatric disorders is promising. TBIs have the potential to provide a cost-effective platform for delivering integrated treatments. The strongest support is for TBIs that address problematic alcohol use, depression, or anxiety. Future research should focus on designing more RCTs of comorbid TBIs and on developing TBIs that address SUDs and comorbid eating disorders and psychotic disorders. Ways of leveraging the full capabilities of what technology can offer should also be explored.
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